Ergo Bioscience
PrivateLast Round
Seed
Oct 17, 2024
Total Funding Raised
$2.5M
Company Overview
Ergo Bioscience operates in Healthcare & Life Sciences and is based in Sunchales. Its latest recorded funding round was a Seed round in October 2024.
Ergo Bioscience is a biotechnology company that develops plant-based protein ingredients using precision fermentation of plant cells to create realistic meat and dairy alternatives.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ergo Bioscience Comparables
Compare Ergo Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neoproteins | 87% | |
| Asterix Foods | 86% | |
| Kyomei | 85% |
For institutional investors. Book with your work email.
Ergo Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 17, 2024 | ||||
| Accelerator | Sep 19, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ergo Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eatable Adventures | Accelerator |
| CITES | Accelerator, Seed |
| Ag-West Bio Inc. | Seed |
| Pascual Innoventures | Accelerator, Seed |
| Global Agri-Food Advancement Partnership | Seed |
| ProVeg International | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2024
$2M raised from Pascual Innoventures and CITES.
- Sep 19, 2023
$500K raised from Eatable Adventures and others.
For institutional investors. Book with your work email.
Ergo Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ergo Bioscience's valuation, stock price, and market status.
Is Ergo Bioscience a public or private company?
Ergo Bioscience is a private company.
What is the current stock price of Ergo Bioscience?
Ergo Bioscience is a private company, so its shares have no public market price. Caplight tracks Ergo Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ergo Bioscience worth (valuation)?
Valuation information for Ergo Bioscience is not publicly available.
Can I buy Ergo Bioscience stock?
Ergo Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ergo Bioscience's last funding round?
Ergo Bioscience's most recent funding round was Seed on October 17, 2024.
Who are the main investors in Ergo Bioscience?
Key investors in Ergo Bioscience include Eatable Adventures, CITES, Ag-West Bio Inc., Pascual Innoventures, Global Agri-Food Advancement Partnership.
Will Ergo Bioscience IPO soon?
No public IPO plans have been announced for Ergo Bioscience.
How can I track Ergo Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Ergo Bioscience's shares on secondary markets.